Estrogen receptor-α; peroxisome proliferation–activated receptor-γ coactivator 1α (PPARGC1A; PGC-1α) BriefCommunication Pages: 1293 - 1293
Ixodes scapularis antifreeze glycoprotein (iafgp); poly-N-acetyl glucosamine (PNAG) BriefCommunication Pages: 1294 - 1294
Sphingosine 1-phosphate receptor 3 (S1PR3; S1P3; EDG3); calcitonin receptor BriefCommunication Pages: 1296 - 1296
Sterol O-aceyltransferase 1 (SOAT1; ACAT1); β-amyloid (Aβ); Aβ42 BriefCommunication Pages: 1297 - 1297
Somatic mutation finder (SMUFIN) to identify single-nucleotide variants (SNVs) and structural variants in tumor DNA BriefCommunication Pages: 1299 - 1299
Clustered, regularly interspaced short palindromic repeats (CRISPR)-Cas9 genome editing for creating mice bearing oncogenic chromosomal arrangements BriefCommunication Pages: 1300 - 1300
Protein nanocapsules for tumor-targeted delivery of recombinant p53 protein BriefCommunication Pages: 1301 - 1301
CD8 + T cells that express phosphopeptide-targeted T cell receptor (TCR) to treat cancer BriefCommunication Pages: 1302 - 1302
Cell therapy for Parkinson's disease (PD) using dopamine-like neurons differentiated from induced primitive neural stem cells BriefCommunication Pages: 1303 - 1303
Human pluripotent stem cell–derived intestinal organoids with in vivo functionality BriefCommunication Pages: 1304 - 1304
Microcapillary rheometer for obtaining viscosity measurements of therapeutic protein solutions BriefCommunication Pages: 1305 - 1305
Non–small cell lung cancer (NSCLC) tumor heterogeneity as a predictor of disease outcomes BriefCommunication Pages: 1307 - 1307